Skip to content
healthcare.dev

Pyridostigmine Bromide

NDC 58657-811, PYRIDOSTIGMINE BROMIDE, tablet, from Method Pharmaceuticals, LLC.

Product NDC
58657-811
Status
Listed
Labeler
Method Pharmaceuticals, LLC
Dosage form
TABLET
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA211181
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/58657-811 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • PYRIDOSTIGMINE BROMIDE60 mg/1

Pharmacologic classes

Cholinesterase Inhibitor [EPC]; Cholinesterase Inhibitors [MoA]

Package NDCNDC-11Package
58657-811-0158657081101100 TABLET in 1 BOTTLE (58657-811-01)
58657-811-305865708113030 TABLET in 1 BOTTLE (58657-811-30)
58657-811-905865708119090 TABLET in 1 BOTTLE (58657-811-90)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/1aa7a886-c726-cc91-e063-6294a90a1af1

Use it

Look up 58657-811 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/58657-811 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 58657-811. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.